1. Muscle manifestations and CK levels in COVID infection: results of a large cohort of patients inside a Pandemic COVID-19 Area
- Author
-
De Rosa, Corrao, Alessandro, Merlo, Prelle, Ivan, Siciliano, Giovanni, Pinuccia Verrengia, Gabriele, Anna, Federico, Rea, Elena, De Rosa, A, Verrengia, E, Merlo, I, Rea, F, Siciliano, G, Corrao, G, and Prelle, A
- Subjects
Male ,2019-20 coronavirus outbreak ,myalgia ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Coronaviru ,Pneumonia, Viral ,coronavirus ,Article ,Pandemic ,Medicine ,Humans ,Creatine Kinase ,Pandemics ,Aged ,Retrospective Studies ,business.industry ,SARS-CoV-2 ,COVID-19 ,Original Articles ,Middle Aged ,Virology ,Arthralgia ,Large cohort ,Neurology ,Italy ,CK ,Hyperkalemia ,Female ,Neurology (clinical) ,business ,Biomarkers - Abstract
Objective: to investigate both muscular manifestations and CK levels of a large cohort of patients with COVID-19 infection and to determine whether hyperckemia is associated with morbidity and mortality.Methods: Data of 615 patients discharged from ASST Ovest Milanese (Milan, Lombardy, Italy) with final diagnosis of COVID-19 infection were retrospectively extracted from electronical medical records from 21 February to 1 May 2020. Patients were descriptively analyzed with respect to the following variables: sex, age, muscular manifestations (including myalgia/arthralgia and fatigue), respiratory involvement (SARS pneumonia or respiratory failure) and history of falls. Association between patients’ characteristics and CK levels was investigated. In addition, the proportion of patients who died following access to the ER was calculated. Finally, the effect of CK levels and other patients’ features on mortality was estimated using a logistic regression model.Results: 176 (28.6%) patients had raised serum CK levels. 88 (14.3%) had muscular manifestations, of which 81 (13.2%) complained fatigue and 17 (2.8%) had myalgia and/or arthralgia. CK levels were significantly associated with respiratory involvement and fatal outcome.Conclusions: Our study provides preliminary evidence that hyperckemia is a predictor of respiratory involvement and fatal outcome in patients with COVID-19 infection. For patients with muscle damage symptoms, screening for COVID-19 infection is recommended together with the dosage of CK level.
- Published
- 2021